Psychedelics Reform Movement Here to Stay, Says NIDA Boss
During a National Institutes for Health workshop on the use of psychedelic drugs as therapeutics, Dr. Nora Volkow, director of the National Institute on Drug Abuse (“NIDA”), suggested that the psychedelics reform movement was here to stay. Volkow stated that individuals would soon start using the substances with or without approval from the FDA, given the attention the drugs had attracted. The director added that the moment was a good opportunity for her as well as her colleagues to change their approach to psychedelic drugs, which have demonstrated their effectiveness in treating various indications, including alcohol use disorder, anxiety, depression…